BindingDB logo
myBDB logout

null

SMILES: CCc1cc(O)c(F)cc1-c1ccc2c(n[nH]c2c1)-c1nc2C[C@H](N(C)Cc2[nH]1)C(=O)N1CC(C1)N(C)C

InChI Key: InChIKey=LVJFCJHEDIELRT-QWEPBSKHSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 488299   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM488299
PNG
(US10954237, Example 8-2)
Show SMILES CCc1cc(O)c(F)cc1-c1ccc2c(n[nH]c2c1)-c1nc2C[C@H](N(C)Cc2[nH]1)C(=O)N1CC(C1)N(C)C |r|
Show InChI InChI=1S/C28H30FN7O2/c1-5-15-9-25(37)20(29)10-19(15)16-6-7-18-21(8-16)32-33-26(18)27-30-22-11-24(35(4)14-23(22)31-27)28(38)36-12-17(13-36)34(2)3/h6-10,17,24,37H,5,11-14H2,1-4H3/b27-26-/t24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0600n/an/an/an/an/an/an/an/a



Theravance Biopharma R&D IP, LLC

US Patent


Assay Description
A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...


US Patent US10954237 (2021)


BindingDB Entry DOI: 10.7270/Q2571G33
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM488299
PNG
(US10954237, Example 8-2)
Show SMILES CCc1cc(O)c(F)cc1-c1ccc2c(n[nH]c2c1)-c1nc2C[C@H](N(C)Cc2[nH]1)C(=O)N1CC(C1)N(C)C |r|
Show InChI InChI=1S/C28H30FN7O2/c1-5-15-9-25(37)20(29)10-19(15)16-6-7-18-21(8-16)32-33-26(18)27-30-22-11-24(35(4)14-23(22)31-27)28(38)36-12-17(13-36)34(2)3/h6-10,17,24,37H,5,11-14H2,1-4H3/b27-26-/t24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.25n/an/an/an/an/an/an/an/a



Theravance Biopharma R&D IP, LLC

US Patent


Assay Description
A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...


US Patent US10954237 (2021)


BindingDB Entry DOI: 10.7270/Q2571G33
More data for this
Ligand-Target Pair